Ewell T, Bomar M, Abbotts K, Butterklee H, Dooley G, Bell C
Front Physiol. 2022; 13:1085822.
PMID: 36545283
PMC: 9760823.
DOI: 10.3389/fphys.2022.1085822.
Muzaffar A, Ullah S, Subhan F, Nazar Z, Hussain S, Khuda F
Front Psychiatry. 2021; 12:730388.
PMID: 34925083
PMC: 8678041.
DOI: 10.3389/fpsyt.2021.730388.
Parks C, Jones B, Moore B, Mulligan M
Cannabis Cannabinoid Res. 2020; 5(3):231-245.
PMID: 32923660
PMC: 7480727.
DOI: 10.1089/can.2019.0047.
Ramaekers J, van Wel J, Spronk D, Toennes S, Kuypers K, Theunissen E
Sci Rep. 2016; 6:26843.
PMID: 27225696
PMC: 4881034.
DOI: 10.1038/srep26843.
Rosenberg E, Tsien R, Whalley B, Devinsky O
Neurotherapeutics. 2015; 12(4):747-68.
PMID: 26282273
PMC: 4604191.
DOI: 10.1007/s13311-015-0375-5.
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.
Lee D, Schroeder J, Karschner E, Goodwin R, Hirvonen J, Gorelick D
Am J Addict. 2014; 23(3):234-42.
PMID: 24724880
PMC: 3986824.
DOI: 10.1111/j.1521-0391.2014.12088.x.
Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia.
Koola M, Boggs D, Kelly D, Liu F, Linthicum J, Turner H
Psychiatry Res. 2013; 209(3):273-8.
PMID: 23969281
PMC: 3804059.
DOI: 10.1016/j.psychres.2013.07.044.
Marijuana dependence: not just smoke and mirrors.
Ramesh D, Schlosburg J, Wiebelhaus J, Lichtman A
ILAR J. 2013; 52(3):295-308.
PMID: 23382144
PMC: 3606907.
DOI: 10.1093/ilar.52.3.295.
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.
Levin K, Copersino M, Heishman S, Liu F, Kelly D, Boggs D
Drug Alcohol Depend. 2010; 111(1-2):120-7.
PMID: 20510550
PMC: 2930056.
DOI: 10.1016/j.drugalcdep.2010.04.010.
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
Cooper Z, Haney M
Int Rev Psychiatry. 2009; 21(2):104-12.
PMID: 19367504
PMC: 2731700.
DOI: 10.1080/09540260902782752.
Cannabis withdrawal in the United States: results from NESARC.
Hasin D, Keyes K, Alderson D, Wang S, Aharonovich E, Grant B
J Clin Psychiatry. 2008; 69(9):1354-63.
PMID: 19012815
PMC: 2777674.
DOI: 10.4088/jcp.v69n0902.
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper Z, Haney M
Addict Biol. 2008; 13(2):188-95.
PMID: 18279497
PMC: 2731704.
DOI: 10.1111/j.1369-1600.2007.00095.x.
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
Tanda G, Goldberg S
Psychopharmacology (Berl). 2003; 169(2):115-34.
PMID: 12827346
DOI: 10.1007/s00213-003-1485-z.
Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man.
Cocchetto D, Owens S, PEREZ-REYES M, DiGuiseppi S, Miller L
Psychopharmacology (Berl). 1981; 75(2):158-64.
PMID: 6275440
DOI: 10.1007/BF00432179.
Tolerance to, and symmetrical cross-tolerance between, cannabinol and delta 9-tetrahydrocannabinol.
Fish B, Consroe P
Experientia. 1981; 37(3):295-6.
PMID: 6263678
DOI: 10.1007/BF01991664.